Dr. Khismatullin is a member of the international team who has been awarded a grant from Skolkovo Foundation for the project application entitled "The creation of a new treatment for breast cancer on the basis of agents obtained through the neolymphogenesis stimulation and induction". The team leader is Prof. Shamil Gantsev, a prominent Russian oncologist. Other members of the team are Profs. Melody Swartz (EPFL, Switzerland) and Kazuo Umezawa (Keio University and Aichi Medical University, Japan).
